InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,990.02
(
0.15%
)
Post# of 251718
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TwoNE1

Send PM Follow Ignore
Followers 1
Posts 129
Boards Moderated 0
Alias Born 01/27/2011

TwoNE1

Re: ronpopeil post# 239545

Tuesday, 09/14/2021 1:55:28 PM

Tuesday, September 14, 2021 1:55:28 PM

Post# of 251718
Imo good data for a small company like LPTX (market cap below $150M) but also 4 grade 5 AEs they did not explain in their PR.
DKN-01 + tislelizumab + capecitabine/oxaliplatin was well tolerated according to their abstract (no related G3/4 toxicities).
Trial is not on hold.

Hopefully more info on Thursday, 2:30 a.m. ET (ESMO presentation) and at their conference call on Friday, 8:00 a.m. ET.


Any thoughts on the LPTX data the other day?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up